Psychology suggests that people who feel sudden itching sensations in their bodies just before sleep aren't feeling something ...
Quoin Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug ...
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.
Roflumilast 0.05% (Zoryve), a topical phosphodiesterase-4 inhibitor, is currently approved for treating mild-to-moderate AD in children aged 2 years or older; it was approved for ...
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-l ...
Quoin Expects to Initiate Phase 2 Study in 2H 2026, Study Plans to Enroll 6-8 Pediatric and Adult Patients in the U.S. and EuropeFDA Expressed No Safety Concerns Over Study Design and Duration of Dosi ...
In three years under the stewardship of artistic director Hana S. Sharif, Arena Stage at the Mead Center for American Theater ...
The Albanese Labor Government has made three new appointments to two screen boards.Dr Tania Chambers OAM appointed as Deputy Chair to the board of ...
London council 'playing Russian roulette' with lives over management of popular lido - Thousands of visitors are unaware that ...
However, many are unaware that swimming in the West London lido is banned, and local people say the crowds are putting them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results